About
PreComb Therapeutics develops a high-throughput, automated platform that uses patient-derived tumor 3D microtumors to functionally profile and predict drug responses, aiding oncology drug development decisions such as candidate prioritisation, indication selection, and combination strategy design.
Explore PreComb Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.